Healix

Successful Management of Osteomyelitis in Infectious Disease Physician Office Infusion Centers (POICs)

Authors:
John S. Adams, MD, FIDSA, FSHEA – Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Richard C. Prokesch, MD, FACP, FIDSA – Infectious Diseases Associates, Riverdale, GA
Robin H. Dretler, MD, FIDSA – Infectious Disease Specialists of Atlanta, P.C., Decatur, GA
Brian Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX
Quyen Luu, MD – Quyen Luu, MD, Macon, GA
Andrew H. Krinsky, MD – Infectious Diseases Associates, Sarasota, FL
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Inc, Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound